What does Nephrolytics, Inc. do?
Nephrolytics develops an AI-powered clinical intelligence platform called Saya™, which automates SOAP note creation, streamlines clinical workflows, and provides real-time decision support by integrating data from EMRs, labs, hospitals, and HIEs.
How much did they raise?
The company secured $2.5M in a Seed SAFE round with undisclosed backers, reflecting its early-stage investment phase.
What are their plans for the money?
The funds will be used to accelerate product development, expand customer success teams, and enhance onboarding processes for nephrology practices and dialysis organizations, potentially transforming kidney care delivery.
What have they achieved so far?
Nephrolytics has already made significant progress with its flagship platform, Saya™, which improves clinical workflow efficiency and supports decision-making in patient care.
